Tuesday - July 7, 2026
UTMB, Circio partner to evaluate circVec for infectious diseases treatment
January 07, 2026
GALVESTON, Texas, Jan. 7 -- The University of Texas Medical Branch issued the following news release:

* * *

UTMB, Circio partner to evaluate circVec for infectious diseases treatment

*

The University of Texas Medical Branch will partner with Oslo-based biotechnology company Circio Holding ASA to evaluate the use of Circio's circVec therapy for treatment of infectious diseases.

The unique capacity of the circVec technology to . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products